Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Qnexa
Qnexa
Vivus: analysis links ingredient of weight loss drug Qnexa to greater risk of birth defects
Yahoo/AP
Wed, 12/21/11 - 09:09 pm
Qnexa
birth defects
Vivus
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Vivus says FDA accepts weight-loss drug application
Reuters
Fri, 11/4/11 - 09:25 am
FDA
obesity
Vivus
Qnexa
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Bloomberg
Mon, 10/17/11 - 09:30 am
warnings
Vivus
Qnexa
FDA
obesity
Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Mon, 10/3/11 - 11:15 am
Qnexa
obesity
Vivus
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Arena Pharmaceuticals
Orexigen
Vivus
Qnexa
weight loss
obesity
A Shrinking Obesity Market
Motley Fool
Sat, 09/17/11 - 02:51 pm
weight loss
Vivus
Qnexa
Orexigen
Arena Pharmaceuticals
Vivus plans to resubmit potential diet pill Qnexa to FDA next month
Yahoo/AP
Thu, 09/15/11 - 11:52 am
obesity
Vivus
FDA
Qnexa
FDA Bullies Obesity Drugmakers
Motley Fool
Sat, 06/4/11 - 10:06 am
Orexigen
Contrave
Vivus
Qnexa
Arena Pharmaceuticals
obesity
weight loss
Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Seeking Alpha
Sat, 05/28/11 - 12:00 pm
Arena Pharmaceuticals
Orexigen
Vivus
obesity
Qnexa
weight loss
Contrave
Epilepsy Drug Study Showing Little Risk May Help Vivus Pill
Bloomberg
Tue, 05/17/11 - 08:53 pm
Vivus
epilepsy
Qnexa
Vivus Still Looking for Ways to Push Diet Drug Forward
Seeking Alpha
Mon, 05/9/11 - 09:19 am
Vivus
obesity
Qnexa
Vivus Puts Obesity Drug On A Diet
TheStreet.com
Tue, 05/3/11 - 09:02 am
Vivus
obesity
Qnexa
What Vivus Fails To Say About Its Diet Pill Study
Pharmalot
Tue, 04/12/11 - 10:06 am
Vivus
Qnexa
obesity
Qnexa Trial Data is Good News for Vivus as Stock Rises
WSJ Online
Mon, 04/11/11 - 11:42 am
Qnexa
Vivus
obesity
Vivus shares Qnexa study data
Yahoo/AP
Mon, 04/4/11 - 09:29 am
obesity
Vivus
Qnexa
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Bloomberg
Fri, 03/4/11 - 10:40 am
Vivus
birth defects
Topamax
JNJ
Qnexa
Analyst Notes: Vivus delivers Qnexa update
Yahoo/AP
Tue, 03/1/11 - 11:33 am
Vivus
obesity
Qnexa
FDA Setbacks Make Vivus a Buying Opportunity
Seeking Alpha
Wed, 02/23/11 - 08:02 am
FDA
Vivus
Qnexa
obesity
Obesity Drugs: The Road to Perdition
TheStreet.com
Tue, 02/1/11 - 11:22 am
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Lorqess
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »